Eiger BioPharmaceuticals Announces FDA Acceptance of IND Application for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies

Author's Avatar
Dec 03, 2018
Article's Main Image

- Plans to File NDA in 2019

PR Newswire